Expert Review of Anticancer Therapy [ISSN 1473-7140]; [e-ISSN 1744-8328] is a MEDLINE-indexed, international journal publishing comprehensive peer-reviewed content on the major issues in clinical oncology.
Coverage in the journal is focused on, but not limited to, the following key areas:
- Anticancer agents
- Novel therapies in development
- Cancer management
- Biomarkers
- Diagnostics
- Clinical trials
- Treatment guidelines
The journal welcomes clinically focused original research, reviews, editorials and drug profile articles.
Please note that the journal does not accept case reports and does not accept papers focused on pre-clinical work and/or animal studies.
Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.
Authors can choose to publish gold open access in this journal and may choose to publish using our Accelerated Publication services.
Read the Instructions for Authors for information on how to submit your article. For any pre-submission enquiries, please contact the Commissioning Editor.
![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110817/Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})